I don't believe that's the case, they have a large IXC holding of which they cover actively due to retail traders success in following their research on PAR. They have quite the following, to the point they found a market for weekly discussions by creating a podcast for this retail following.
Many have peppered them with the "what's the next PAR" question and following phase 2 success and CR, IXC is now in that sleeper category where it's a great ground floor entry point for retail traders imo.
As of their podcast titled "Update: PAR and IVX" from 30th of July, they are taking these prices as continued accumulation.
Is there any reason in particular that you have suspicions of them being on a retainer?
Ann: Initial FDA and EMA Advice on Presendin Development, page-100
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28320 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 22452 | 2 |
View Market Depth
| Last trade - 16.12pm 06/09/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable